Skip to content
naulon
Not checkedNot checked for notices yet.

Incidence of Metabolic Syndrome in Anti-Hepatitis C Virus Positive Patients

Mehmet Emirhan Işık, Arzu Cennet Işık, Semra Özgümüş and 3 more

Southern Clinics of Istanbul Eurasia · 2021

doi:10.14744/scie.2020.87059 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

INTRODUCTION[|]Research has shown that hepatitis C infection, metabolic syndrome (MS), and non-alcoholic fatty liver syndrome are associated. This study was designed to assess the parameters of MS in people with hepatitis C antibodies.[¤]METHODS[|]We enrolled 104 patients, including 52 men and 52 women who visited our hospital and had anti-hepatitis C virus (HCV) positivity. In the patient group, different examinations were performed as per the MS criteria in the Adult Treatment Panel (ATP) III and International Diabetes Federation (IDF) guidelines.[¤]RESULTS[|]As per the ATP III criteria, the prevalence of MS was 36.5% (n=38) in the total population, 55.8% (n=29) in women, and 17.3% (n=9) in men in our study. When the IDF criteria were applied, the MS prevalence was 48.1% (n=50) in the total population, 65.4% (n=34) in women, and 30.8% (n=16) in men.[¤]DISCUSSION AND CONCLUSION[|]In our study, the prevalence of MS was significantly higher in female patients with HCV antibodies than in male patients.[¤]

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.